Peer Review History
| Original SubmissionJune 9, 2021 |
|---|
|
PONE-D-21-18947 Multimorbidity Clustering of the Emergency Department Patient Flow: Impact Analysis of New Unscheduled Care Clinics PLOS ONE Dear Dr. Sanchez, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 16 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Yong-Hong Kuo Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. You indicated that ethical approval was not necessary for your study since this was as retrospective study based on fully anonymized data as such ethics approval is not required under the French Law. Please clearly clarify this within the ethics statement of the manuscript text and the online submission form, ensuring that you have specified that all data was fully anonymised prior to access 3. Thank you for stating the following financial disclosure: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." At this time, please address the following queries: a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” c) If any authors received a salary from any of your funders, please state which authors and which funders. d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf Additional Editor Comments (if provided): The submission has been reviewed by two experts in the area. Both of them believe that this work has merit and is interesting to the reader. Both referees have provided constructive suggestions to the authors to improved the work. The authors shall consider them in the revision. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I believe that it is a useful study for the emergency room overcrowding, which has become a global problem. In the study of the authors, it was observed that there was no ethical defect or a situation where there could be a conflict of interest. Reviewer #2: Dear editor in chief, dear authors I thank the Editor for the opportunity to review this manuscript which investigates the impact of the opening of unscheduled care structures on the activity of an emergency service. The authors propose an analysis based on multmorbidity clustering of the ED patients. This analysis is very interesting. However, the article requires revisions before it can be considered for publication. Major points: Method Line 143: Between October and November 2018 the opening of two new UCS facilities offering services akin to convenient care clinics changed the organization of emergency care delivery in the city. It is important to locate the UCS in relation to the hospital to know if access is easy, which would be an argument for assuming that patients who go to the hospital are those who go to these facilities In addition, it is important to describe the health capacity of the city: number of clinics and other facilities where the hospital patients could have gone. Line 150: The 2-year study period was chosen to account for the yearly seasonal variations However, in line 197, it appears that the study is done 18 months before and 6 months after. What is the justification for not taking a year after opening to have the variation over a full year? I am not an expert in statistics, nevertheless an time series analysis could be used considering that opening UCS is an intervention. Results Page 9, Line 216: Who enters the ICD10 diagnosis codes? Is it emergency physicians only or can others such as residents or non-medical staff do the entry? How is the reliability of code entry verified in the hospital? This data should be clarified to better understand the analysis of evolution of ED visits Discussion Page 11, Line 275: We understand the decrease in traumatological pathologies with the opening of such units, but how can we explain the increase in infectious and chronic pathologies? Hypotheses could be evoked to develop the discussion. In any case, it shows the change of behavior in the society and the way of treating oneself. In addition, it is important to describe the health capacity of the city: the number of clinics and other facilities to which the hospital patients could have gone. For example, if a private hospital opened, this may also influence patient flow. Is it easy to get to the hospital and the UCS? These are also factors that can influence the choice of going to a particular facility, beyond the economic factor. Studies exist on the profile of patients consulting ED for non-urgent pathologies and on the choice of patients to come to ED rather than to use such facilities. it would be desirable to discuss the factors that could influence patients to go to ED or to these facilities This element could be discussed Finally, an analysis of flows based on patient severity could be interesting, for example, based on a classification of patients according to triage scales (Manchester triage scale, Canadian triage and acuity scale, The Emergency Severity Index, CIMU in France…). Are the patients who used to come to the emergency room and who use these new structures the least serious? The choice of ICD10 rather than these scales should be discussed? Minor points Methods Line 157 : triage path For those who are not familiar with the organization of EDs, it is difficult to understand the triage process. We can imagine that the scale used is a validated scale (like the Canadian triage and acuity scale, CIMU in France, or other...) From which software are the data of the patients consulting the emergency room extracted? Results Adding the estimated size of effect and its precision communicates what range of outcomes would be probable if the trail were repeated multiple times. It would be interesting to have the confidence interval (for example line 261) The authors should probably limit the number of decimal places for the p-value, and I suggest noting <0.0001 for values below this threshold Tables: Table 2 should include the IC95% to better analyze the differences obtained. Table 3: legend should be added (PS1, ED...) Figures: Figure 3: the scale of the y-axis could be changed to make the box plot more readable Once again, thank you for the opportunity to review this article. Best regards DAG ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Daniel Aiham GHAZALI [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Multimorbidity clustering of the Emergency Department patient flow: impact analysis of new unscheduled care clinics PONE-D-21-18947R1 Dear Dr. Sanchez, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Yong-Hong Kuo Academic Editor PLOS ONE Additional Editor Comments (optional): The referee who had concerns about the work reviewed the revision and is satisfied with the revised work. Based on the recommendations and comments from the referees of the two rounds, I recommend Accept. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Dear editor in chief, dear authors I thank the Editor for the opportunity to review this revised manuscript which investigates the impact of the opening of unscheduled care structures on the activity of an emergency service. I thank the authors for responding to all the comments, especially regarding the use of the times series analysis, considering that opening UCS is an intervention. Best regards DAG ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Daniel Aiham GHAZALI |
| Formally Accepted |
|
PONE-D-21-18947R1 Multimorbidity clustering of the Emergency Department patient flow: impact analysis of new unscheduled care clinics Dear Dr. Sanchez: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Yong-Hong Kuo Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .